Search and Browse
Download
Enter Data
BDBM50317700 (4-cyclobutyl-1,4-diazepan-1-yl)((2R,4S)-4-(4-fluorophenoxy)pyrrolidin-2-yl)methanone::CHEMBL1095846
SMILES: Fc1ccc(O[C@@H]2CN[C@H](C2)C(=O)N2CCCN(CC2)C2CCC2)cc1
InChI Key: InChIKey=RKXDBMQRODRNSK-UHFFFAOYSA-N
| Target/Host (Institution) | Ligand | Target/Host Links | Ligand Links | Trg + Lig Links | Ki nM | ΔG° kcal/mole | IC50 nM | Kd nM | EC50 nM | koff s-1 | kon M-1s-1 | pH | Temp °C |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Potassium voltage-gated channel subfamily H member 2 (Human) | BDBM50317700![]() ((4-cyclobutyl-1,4-diazepan-1-yl)((2R,4S)-4-(4-fluo...) | GoogleScholar | UniChem | n/a | n/a | 7.80E+3 | n/a | n/a | n/a | n/a | n/a | n/a | |
TBA | Citation and Details | ||||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| Potassium voltage-gated channel subfamily H member 2 (Human) | BDBM50317700![]() ((4-cyclobutyl-1,4-diazepan-1-yl)((2R,4S)-4-(4-fluo...) | GoogleScholar | UniChem | n/a | n/a | >1.00E+4 | n/a | n/a | n/a | n/a | n/a | n/a | |
TBA | Citation and Details | ||||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| Potassium voltage-gated channel subfamily H member 2 (Human) | BDBM50317700![]() ((4-cyclobutyl-1,4-diazepan-1-yl)((2R,4S)-4-(4-fluo...) | GoogleScholar | UniChem | n/a | n/a | 1.00E+4 | n/a | n/a | n/a | n/a | n/a | n/a | |
TBA | Citation and Details | ||||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| Histamine H3 receptor (Human) | BDBM50317700![]() ((4-cyclobutyl-1,4-diazepan-1-yl)((2R,4S)-4-(4-fluo...) | GoogleScholar | UniChem | 1.60 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | |
TBA | Citation and Details | ||||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| Histamine H3 receptor (Human) | BDBM50317700![]() ((4-cyclobutyl-1,4-diazepan-1-yl)((2R,4S)-4-(4-fluo...) | GoogleScholar | UniChem | 1.60 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | |
TBA | Citation and Details | ||||||||||||
| More data for this Ligand-Target Pair | |||||||||||||